Heparan Sulfate Biosynthesis: Methods for Investigation of the Heparanosome

Por Multhaupt, Hinke A. B., Couchman, John R.
Publicado em 2012

The Rho kinases I and II regulate different aspects of myosin II activity

Por Yoneda, Atsuko, Multhaupt, Hinke A.B., Couchman, John R.
Publicado em 2005

Protein Kinase C, Focal Adhesions and the Regulation of Cell Migration

Por Fogh, Betina S., Multhaupt, Hinke A.B., Couchman, John R.
Publicado em 2014

Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II

Por Yoneda, Atsuko, Ushakov, Dmitriy, Multhaupt, Hinke A.B., Couchman, John R.
Publicado em 2007

Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans

Por Yoneda, Atsuko, Lendorf, Maria E., Couchman, John R., Multhaupt, Hinke A. B.
Publicado em 2012

Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma

Por Lendorf, Maria E., Manon-Jensen, Tina, Kronqvist, Pauliina, Multhaupt, Hinke A. B., Couchman, John R.
Publicado em 2011

Heparan Sulfate Chain Valency Controls Syndecan-4 Function in Cell Adhesion

Por Gopal, Sandeep, Bober, Adam, Whiteford, James R., Multhaupt, Hinke A. B., Yoneda, Atsuko, Couchman, John R.
Publicado em 2010

IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules

Por Afratis, Nikolaos A., Bouris, Panagiotis, Skandalis, Spyros S., Multhaupt, Hinke A., Couchman, John R., Theocharis, Achilleas D., Karamanos, Nikos K.
Publicado no Sci Rep (2017)

Serine 34 Phosphorylation of Rho Guanine Dissociation Inhibitor (RhoGDIα) Links Signaling from Conventional Protein Kinase C to RhoGTPase in Cell Adhesion

Por Dovas, Athanassios, Choi, Youngsil, Yoneda, Atsuko, Multhaupt, Hinke A. B., Kwon, Seung-Hae, Kang, Dongmin, Oh, Eok-Soo, Couchman, John R.
Publicado em 2010

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

Por Kullmann, F, Hollerbach, S, Dollinger, M M, Harder, J, Fuchs, M, Messmann, H, Trojan, J, Gäbele, E, Hinke, A, Hollerbach, C, Endlicher, E
Publicado em 2009

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

Por Hoehler, T, von Wichert, G, Schimanski, C, Kanzler, S, Moehler, M H, Hinke, A, Seufferlein, T, Siebler, J, Hochhaus, A, Arnold, D, Hallek, M, Hofheinz, R, Hacker, U T
Publicado em 2013

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil i...

Por Wilkowski, R, Boeck, S, Ostermaier, S, Sauer, R, Herbst, M, Fietkau, R, Flentje, M, Miethe, S, Boettcher, H D, Scholten, T, Bruns, C J, Rau, H G, Hinke, A, Heinemann, V
Publicado em 2009

Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels

Por Gopal, Sandeep, Søgaard, Pernille, Multhaupt, Hinke A.B., Pataki, Csilla, Okina, Elena, Xian, Xiaojie, Pedersen, Mikael E., Stevens, Troy, Griesbeck, Oliver, Park, Pyong Woo, Pocock, Roger, Couchman, John R.
Publicado no J Cell Biol (2015)

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine

Por Theocharis, Achilleas D., Skandalis, Spyros S., Neill, Thomas, Multhaupt, Hinke A. B., Hubo, Mario, Frey, Helena, Gopal, Sandeep, Gomes, Angélica, Afratis, Nikos, Lim, Hooi Ching, Couchman, John R., Filmus, Jorge, Sanderson, Ralph D., Schaefer, Liliana, Iozzo, Renato V., Karamanos, Nikos K.
Publicado no Biochim Biophys Acta (2015)